SI1407776T1 - Farmacevtski koloidni pripravek, ki vsebuje biopolimere hialuronske kisline, uporaben pri zdravljenju respiratornih bolezni - Google Patents

Farmacevtski koloidni pripravek, ki vsebuje biopolimere hialuronske kisline, uporaben pri zdravljenju respiratornih bolezni

Info

Publication number
SI1407776T1
SI1407776T1 SI200230763T SI200230763T SI1407776T1 SI 1407776 T1 SI1407776 T1 SI 1407776T1 SI 200230763 T SI200230763 T SI 200230763T SI 200230763 T SI200230763 T SI 200230763T SI 1407776 T1 SI1407776 T1 SI 1407776T1
Authority
SI
Slovenia
Prior art keywords
hyaluronic acid
composition
treatment
mixture
respiratory diseases
Prior art date
Application number
SI200230763T
Other languages
English (en)
Inventor
Giuseppe Petrigni
Luigi Allegra
Original Assignee
Flostock Llc
Atlas 2002 Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flostock Llc, Atlas 2002 Llc filed Critical Flostock Llc
Publication of SI1407776T1 publication Critical patent/SI1407776T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200230763T 2002-10-10 2002-10-11 Farmacevtski koloidni pripravek, ki vsebuje biopolimere hialuronske kisline, uporaben pri zdravljenju respiratornih bolezni SI1407776T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/267,863 US7060691B2 (en) 2002-10-10 2002-10-10 Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
EP02022717A EP1407776B1 (en) 2002-10-10 2002-10-11 A pharmaceutical colloidal preparation comprising hyaluronic acid biopolymers useful in the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
SI1407776T1 true SI1407776T1 (sl) 2009-04-30

Family

ID=32737409

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230763T SI1407776T1 (sl) 2002-10-10 2002-10-11 Farmacevtski koloidni pripravek, ki vsebuje biopolimere hialuronske kisline, uporaben pri zdravljenju respiratornih bolezni

Country Status (8)

Country Link
US (1) US7060691B2 (sl)
EP (1) EP1407776B1 (sl)
AT (1) ATE406904T1 (sl)
DE (1) DE60228717D1 (sl)
DK (1) DK1407776T3 (sl)
ES (1) ES2314015T3 (sl)
PT (1) PT1407776E (sl)
SI (1) SI1407776T1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0416397D0 (en) * 2004-07-22 2004-08-25 Glaxo Group Ltd Pharmaceutical formulations
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
WO2007021900A2 (en) * 2005-08-10 2007-02-22 Cutler Robert S Compositions and methods for treating wounds
NO20064337L (no) * 2005-09-26 2007-03-27 Glycoscience Lab Inc Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
EP1994934A4 (en) 2006-12-05 2010-03-10 Glycoscience Lab Inc THERAPEUTIC AGENT AGAINST DEGENERATIVE ARTHRITIS
EP2545925B1 (en) * 2011-07-12 2018-02-14 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
FR2977494B1 (fr) * 2011-07-08 2013-08-16 Ayawane Compositions cosmetiques ou pharmaceutiques contenant des acides hyaluroniques de masses moleculaires differentes
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) * 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
IT202000016984A1 (it) 2020-07-13 2022-01-13 Bmg Pharma S P A Composizioni igienizzanti e antiinfettive per le mucose orali
EP3991717A1 (en) * 2020-11-03 2022-05-04 SanderStrothmann GmbH Anti-wrinkle cosmetic composition
WO2023079072A1 (en) * 2021-11-05 2023-05-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
US5633003A (en) * 1994-03-31 1997-05-27 Cantor; Jerome O. Use of intratracheally administered hyaluronic acid to ameliorate emphysema
JP2000502714A (ja) * 1996-01-11 2000-03-07 ハイアル ファーマスティカル コーポレイション ヒアルロン酸の型の有効量の経口投与
US6383344B1 (en) * 2000-07-19 2002-05-07 Genzyme Corporation Molecular weight reduction of polymer using irradiation treatment
AU2001281368B2 (en) * 2000-07-31 2005-07-28 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates

Also Published As

Publication number Publication date
ES2314015T3 (es) 2009-03-16
US20040071740A1 (en) 2004-04-15
DE60228717D1 (de) 2008-10-16
PT1407776E (pt) 2008-12-16
EP1407776A1 (en) 2004-04-14
DK1407776T3 (da) 2009-01-19
ATE406904T1 (de) 2008-09-15
US7060691B2 (en) 2006-06-13
EP1407776B1 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
Mathé et al. Effect of prostaglandins F2α and E2 on airway conductance in healthy subjects and asthmatic patients
SI1407776T1 (sl) Farmacevtski koloidni pripravek, ki vsebuje biopolimere hialuronske kisline, uporaben pri zdravljenju respiratornih bolezni
GB2430623A (en) Medicaments for treating chronic respiratory disease
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
WO2003011327A3 (en) Secretin for the treatment of asthma
CA2519175A1 (en) A method of treating a systemic disease
EP1429712B1 (en) Method for treating bronchial constriction and bronchospasm
Marrett Halothane: its use in closed circuit
AU2002323191A1 (en) Method for treating bronchial constriction and bronchospasm
JP2005501068A (ja) 特に眼科分野における適用のための外傷および損傷の治癒および／または修復のための治療に適したアミノ酸組成物
CN106667974A (zh) 一种吸入用硫酸特布他林溶液制备方法
Snow On the fatal cases of inhalation of chloroform
WO1995028944A1 (en) Pharmaceutical inhalation compositions containing a solid active ingredient
JPS63165324A (ja) メントールの誘導体を含有する薬剤
WO2022063320A1 (zh) 一种抑制呼吸道病毒的组合物及呼吸道病毒防治方法
Nørrelykke Nissen et al. Corneal ulcer after exposure to vapours from bone cement (methyl metacrylate and hydroquinone)
JP4671092B2 (ja) ウイルス感染予防および対策
Lichtenberg Mercury Vapour in the Oral Cavity in Relation to the Number of Amalgam Surfaces and the Classic Symptoms of Chronic Mercury Poisoning
JP2002030000A (ja) 風邪根本治療法
Hj Nitrous oxide. Should it still be used in pediatric medicine?(part 1)
Israel et al. 66 Levalbuterol is effective in the prevention of cold air induced bronchospasm and des not induce tachyphylaxis in the degree of bronchoprotection
Arai et al. The formaldehyde inspiration by the child patient, dentist, and dental assistant during formocresol pulpotomy
CN115089634A (zh) 一种防治新冠肺炎的牛黄/精油组合物及制备方法与应用
Seldin Use of Nitrous Oxide-Oxygen Anesthesia in Dental Surgery.
RU1811407C (ru) Способ лечени бронхиальной астмы